Načítá se...
Control of Graves’ hyperthyroidism with very long-term methimazole treatment: a clinical trial
BACKGROUND: Long-term antithyroid drug therapy has become one of the options for treatment of Graves’ hyperthyroidism. The aim of this study was to compare thyroid status in those who discontinued methimazole (MMI) treatment after 12.8 years with those who continued MMI as long as 24 years. METHODS:...
Uloženo v:
| Vydáno v: | BMC Endocr Disord |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7807686/ https://ncbi.nlm.nih.gov/pubmed/33446181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-00670-w |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|